Simplex Trading
FULC icon

Simplex Trading’s Fulcrum Therapeutics FULC Stock Holding History

Simplex Trading’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-21,800
Closed -$247K – 9428
2025
Q4 		$247K Buy
21,800
+19,400
+808% +$197K ﹤0.01% 4017
2025
Q3 		$22K Sell
2,400
-1,400
-37% -$10.1K ﹤0.01% 7247
2025
Q2 		$26K Buy
3,800
+1,500
+65% +$8.02K ﹤0.01% 6528
2025
Q1 		$6K Sell
2,300
-101,900
-98% -$374K ﹤0.01% 7434
2024
Q4 		$489K Sell
104,200
-139,100
-57% -$513K ﹤0.01% 3562
2024
Q3 		$868K Buy
243,300
+151,500
+165% +$1.12M ﹤0.01% 3049
2024
Q2 		$569K Sell
91,800
-11,100
-11% -$84.1K ﹤0.01% 3527
2024
Q1 		$971K Buy
102,900
+82,600
+407% +$737K ﹤0.01% 3152
2023
Q4 		$137K Buy
20,300
+1,300
+7% +$5.77K ﹤0.01% 5062
2023
Q3 		$84K Buy
19,000
+7,500
+65% +$32.8K ﹤0.01% 5265
2023
Q2 		$37K Sell
11,500
-2,800
-20% -$8.23K ﹤0.01% 6130
2023
Q1 		$40K Buy
14,300
+2,600
+22% +$23.3K ﹤0.01% 6166
2022
Q4 		$85K Sell
11,700
-14,200
-55% -$92.6K ﹤0.01% 5270
2022
Q3 		$209K Sell
25,900
-1,900
-7% -$13.6K ﹤0.01% 4548
2022
Q2 		$136K Buy
27,800
+24,600
+769% +$240K ﹤0.01% 5133
2022
Q1 		$75K Sell
3,200
-20,300
-86% -$287K ﹤0.01% 6545
2021
Q4 		$415K Buy
+23,500
New +$466K ﹤0.01% 4069

Other funds holding FULC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
FTM
First Turn Management Del Mar, California $895M AUM 261.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Simplex Trading's FULC Position: Q1 2026 in Review

Simplex Trading increased its Fulcrum Therapeutics (FULC) stake by 423% in Q1 2026, buying an estimated $315K and bringing the position to 41,940 shares worth $322K. The position accounts for ﹤0.01% of the portfolio, ranked #3749.

Simplex Trading first reported a position in FULC in Q1 2022 and has held it in 14 quarters since. The position peaked at $752K in Q2 2025. 169 funds tracked by Wall St. Rank hold FULC as of Q1 2026.

  • Simplex Trading held 41,940 shares of Fulcrum Therapeutics worth $322K as of Q1 2026.
  • Simplex Trading bought 33,926 Fulcrum Therapeutics shares in Q1 2026, an estimated $315K.
  • Fulcrum Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3749 holding.
  • Simplex Trading first reported a position in Fulcrum Therapeutics in Q1 2022 and has held it in 14 quarters since.
  • Simplex Trading's Fulcrum Therapeutics position peaked at $752K in Q2 2025.
  • 169 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.